PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
02-Sep-2025 Thermo Fisher Scientific Completes Acquisition of Solventum’s Purification and Filtration Business Businesswire
02-Sep-2025 Agilent’s MMR IHC Panel pharmDx (Dako Omnis) Receives European IVDR Certification as a Companion Diagnostic Test for Colorectal Cancer Businesswire
02-Sep-2025 Revvity Establishes In Vivo Imaging Center of Excellence in North Carolina Businesswire
02-Sep-2025 Encoded Therapeutics Announces Regenerative Medicine Advanced Therapy (RMAT) Designation Granted by U.S. FDA for ETX101 in SCN1A+ Dravet Syndrome Businesswire
02-Sep-2025 United Therapeutics Corporation Announces TETON-2 Pivotal Study of Tyvaso® Meets Primary Endpoint for the Treatment of Idiopathic Pulmonary Fibrosis Businesswire
02-Sep-2025 Stoke Therapeutics and Biogen Present Data at the 36th International Epilepsy Congress that Support the Potential for Zorevunersen to be the First Disease-Modifying Medicine for Dravet Syndrome Businesswire
02-Sep-2025 Adicet Bio to Present at the H.C. Wainwright 27th Annual Global Investment Conference Businesswire
02-Sep-2025 Merck’s Investigational Oral PCSK9 Inhibitor Enlicitide Decanoate Met All Primary and Key Secondary Endpoints in Adults with Hypercholesterolemia in Pivotal CORALreef Lipids Study Businesswire
02-Sep-2025 Merck to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference Businesswire
02-Sep-2025 Compass Pathways Announces Publication of Results from Phase 2 Study of COMP360 Psilocybin for Post-Traumatic Stress Disorder Businesswire
02-Sep-2025 ICON plc to Participate at Upcoming Investor Conferences Businesswire
02-Sep-2025 US Food and Drug Administration (FDA) Approves Henlius and Organon’s BILDYOS® (denosumab-nxxp) and BILPREVDA® (denosumab-nxxp), Biosimilars to PROLIA (denosumab) and XGEVA (denosumab), Respectively Businesswire
02-Sep-2025 Mainz Biomed Announces Registration of ColoAlert in the United Kingdom Mainz BioMed N.V.
02-Sep-2025 Releaf Acquires Domain Releaf.com for £110,000 ACCESS Newswire
02-Sep-2025 Releaf Acquires Domain Releaf.com for £110,000 ACCESS Newswire
02-Sep-2025 Polpharma Biologics and MS Pharma Sign Licensing Agreements for Proposed Vedolizumab (PB016), Ocrelizumab (PB018) and Guselkumab (PB019) Biosimilars Businesswire
02-Sep-2025 £22 million NIHR investment to strengthen UK health and life sciences innovation Newcastle University
02-Sep-2025 Therapeutic potential for PEPITEM in osteoporosis University of Birmingham
02-Sep-2025 Terumo BCT and PwC Belgium Join Forces to Break Barriers in Access to Advanced Cell and Gene Therapies Terumo BCT
02-Sep-2025 eXmoor Pharma and Anthony Nolan Cell Therapy and Laboratory Services to offer end-to-end support for cell therapy developers eXmoor Pharma